HPLC-UV-HRMS analysis of cannabigerovarin and cannabigerobutol, the two impurities of cannabigerol extracted from hemp
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 203, 114215
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-TetrahydrocannabiphorolScientific Reports, 2019
- Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analogData in Brief, 2019
- Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analogJournal of Pharmaceutical and Biomedical Analysis, 2019
- A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in CannabisScientific Reports, 2018
- Differential effectiveness of selected non‐psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatmentExperimental Dermatology, 2016
- Non‐THC cannabinoids inhibit prostate carcinoma growthin vitroandin vivo: pro‐apoptotic effects and underlying mechanismsBritish Journal of Pharmacology, 2012
- Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammationActa Physiologica, 2011
- The inheritance of chemical phenotype in Cannabis sativa L. (II): Cannabigerol predominant plantsEuphytica, 2005
- NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativaPhytochemical Analysis, 2004
- Cannabichromevarin and cannabigerovarin, two new propyl homologues of cannabichromene and cannabigerol.Chemical and Pharmaceutical Bulletin, 1975